Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 13/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 13/20 | 0.56 |
| ▸ | F10 | P00742 | 2/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9257983 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BF10F2NQO2 | |
| SCHEMBL9256866 | 0.89 | ITGB3 (0.42) | ITGB3ITGA2BF10F2NQO2 | |
| SCHEMBL9258658 | 0.89 | ITGB3 (0.42) | ITGB3ITGA2BF10F2NQO2 | |
| SCHEMBL7281934 | 0.80 | ITGB3 (0.58) | ITGB3ITGA2BF10F2NQO2 | |
| Hydrochloric Acid SCHEMBL7274050 | 0.79 | ITGB3 (0.57) | ITGB3ITGA2BF10F2NQO2 | |
| SCHEMBL9254707 | 0.78 | ITGB3 (0.52) | ITGB3ITGA2BF10F2NQO2 | |
| SCHEMBL7281612 | 0.77 | ITGB3 (0.57) | ITGB3ITGA2BF10F2NQO2 | |
| SCHEMBL7281830 | 0.77 | ITGB3 (0.57) | ITGB3ITGA2BF10F2NQO2 | |
| SCHEMBL7118598 | 0.75 | ITGB3 (0.74) | ITGB3ITGA2BF10F2PRSS1 | |
| SCHEMBL9254812 | 0.75 | ITGB3 (0.57) | ITGB3ITGA2BF10F2NQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5463071-A | Tetrazole derivatives; useful for inhibiting undesirable cell aggregation | DR. KARL THOMAE GMBH (DE) | 1995-10-31 | — | — | US | disclosed |
| EP-0525629-A2 | 5-membered heterocycles, process for their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1993-02-03 | — | — | EP | disclosed |